To the best of our knowledge, this is the first study aimed at identifying factors predicting primary NHA resistance. In our experience of everyday clinical practice in an unselected CRPC ...

NICE is unable to make a recommendation about the use in the NHS of niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer in adults. This is ...

Lynparza for adult patients with deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC), ...

Rethinking Materials and Kraft Heinz are challenging start-ups worldwide to develop new and more sustainable packaging. The competition seeks flexible food packaging solutions that are either ...

The integration of artificial intelligence (AI) in packaging manufacturing has become a necessity. AI is revolutionizing traditional processes, driving efficiency, and creating new opportunities for ...

Abiraterone acetate (CB7630), a pregnenolone analog, is an orally administered small molecule that irreversibly inhibits a rate-limiting enzyme in androgen biosysnthesis, CYP17, and blocks the ...

Abiraterone is under clinical development by Austhera BioSciences and currently in Phase II for Castration-Resistant Prostate Cancer (CRPC). According to GlobalData, Phase II drugs for ...

Australia’s current national co-regulatory framework for packaging was independently reviewed in 2021. The review found that reform of packaging is needed and made 9 recommendations. The government’s ...

Packaging News is offering early bird savings today for Environmental Packaging Live 2025, which unites the Environmental Packaging Summit and the Environmental Packaging Awards. Saica Flex, the ...